114 related articles for article (PubMed ID: 2273706)
1. [Production of monoclonal antibodies against human bladder cancer cells and application to immunohistochemical analysis of bladder cancer].
Saiki S; Meguro N; Morita T; Tomooka Y; Maeda O; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1537-42. PubMed ID: 2273706
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature].
Guo Y
Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):213-5, 254. PubMed ID: 1327448
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
[TBL] [Abstract][Full Text] [Related]
4. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P
Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953
[TBL] [Abstract][Full Text] [Related]
5. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
6. [Production and characterization of a group of monoclonal antibodies to human transitional cell carcinoma].
Guo YL
Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):777-80, 799-800. PubMed ID: 1618045
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody (BL2-10D1) reacting with a bladder-cancer-associated antigen.
Longin A; Hijazi A; Berger-Dutrieux N; Escourrou G; Bouvier R; Richer G; Mironneau I; Fontanière B; Devonec M; Laurent JC
Int J Cancer; 1989 Feb; 43(2):183-9. PubMed ID: 2645218
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization.
Takahashi N; Takahashi S; Takahashi K; Suzuki T; Funyu T
J Urol; 1987 Jul; 138(1):207-11. PubMed ID: 2439711
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of cell types in primary transitional cell carcinoma by monoclonal anti-cytokeratin antibodies.
Reedy EA; Colombo-Burke KL; Resau JH
Pathobiology; 1990; 58(6):304-11. PubMed ID: 1706601
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
12. [Reactivity of anti-human bladder cancer monoclonal antibodies with bladder tumor tissues].
Kagawa S; Takigawa H; Kurokawa K; Masuko T; Hashimoto Y
Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):133-9. PubMed ID: 3723905
[No Abstract] [Full Text] [Related]
13. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
14. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
15. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
18. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
Loy TS; Alexander CJ; Calaluce RD
Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688
[TBL] [Abstract][Full Text] [Related]
19. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization.
Trejdosiewicz LK; Southgate J; Donald JA; Masters JR; Hepburn PJ; Hodges GM
J Urol; 1985 Mar; 133(3):533-8. PubMed ID: 2579255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
